Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / PFE - Sangamo's Hemophilia A Treatment: An Assessment

PFE - Sangamo's Hemophilia A Treatment: An Assessment

Pfizer Inc.
  • Sangamo and licensee Pfizer's SB-525 is competing with BioMarin's ValRox in hemophilia A.
  • There are durability questions surrounding both drugs.
  • However, they will have a positive role to play in this indication.

For further details see:

Sangamo's Hemophilia A Treatment: An Assessment
Stock Information
Company Name: Pfizer Inc.
Stock Symbol: PFE
Market: NYSE
Website: pfizer.com
Menu
PFE PFE Quote PFE Short PFE News PFE Articles PFE Message Board
Get PFE Alerts

News, Short Squeeze, Breakout and More Instantly...